Cardiology: 150 CME educational programs available now

Thrombosis

Cardiovascular Complications After Joint Replacement Surgery: A Crossroad in Anticoagulation

Apr 17, 2013 15:54 EDT

Drs. Goldhaber, Bozic, and Pellegrini discuss appropriate treatment strategies to prevent VTE following major orthopedic surgery.

Thrombosis

How to Manage Patients with VTE

Jan 11, 2013 13:00 EST

Drs. Cohen and Turpie discuss the practicalities of treating patients with VTE using novel oral anticoagulants.

Thrombosis

New Options for the Acute and Prolonged Treatment of Venous Thromboembolism

Jan 3, 2013 11:25 EST

Drs. Turpie, Büller, Agnelli, and Kaatz discuss a new paradigm in the acute and long-term treatment of VTE.

Thrombosis

Getting Smart About Secondary Prevention of VTE: Practical Strategies for the Use of New Therapies

Jan 2, 2013 10:59 EST

Dr. Cohen discusses the risk for VTE recurrence, the need for long-term oral anticoagulation, and effective VTE management.

Thrombosis

The 2012 ESC Atrial Fibrillation Guidelines Focused Update: Concentrating on Stroke Prevention

Dec 24, 2012 09:09 EST

Drs. Camm and De Caterina discuss the importance of stroke risk stratification to ensure appropriate anticoagulation in patients with AF.

Thrombosis

The Overlapping Syndromes of AF and ACS: Are We Doing All We Can for These Patients?

Dec 17, 2012 10:49 EST

Drs. Gibson and Verheugt discuss the challenges of treating patients with AF and ACS and combining antiplatelet and anticoagulation therapy.

Thrombosis

Thrombin and Myocardial Infarction: Implications for Oral Anticoagulation

Dec 12, 2012 11:15 EST

Drs. Fox, Mega, and Steg discuss the benefits and risks of adding anticoagulants to antiplatelets to improve outcomes in patients with MI.

Thrombosis

Preventing Stroke in Patients With Atrial Fibrilation

Nov 29, 2012 14:17 EST

Choose a case from the waiting room on management of stroke prevention in patients with AF with commentary from Drs. Camm, Fox, and Patel.

Thrombosis

Best Practices in Preventing Stroke in Patients With Atrial Fibrillation: Solutions in Everyday Practice

Nov 29, 2012 09:49 EST

Drs. Harrington and Kakkar discuss first-cohort data from the community-based global GARFIELD registry of newly diagnosed patients with AF.

Thrombosis

Duration of Care in Secondary Prevention in ACS

Oct 31, 2012 11:08 EDT

Will an antithrombin-antiplatelet combination be the future of secondary prevention in ACS? Drs. Bode and Huber discuss.

Thrombosis

Preventing AF-Related Stroke in a Patient With Previous Myocardial Infarction

Oct 26, 2012 13:26 EDT

Join Lord Kakkar and Drs Mega and Heidbuchel as they discuss strategies for managing anticoagulation for patients with AF who have an ACS.

Thrombosis

PLATO, ATLAS, and Mortality: Implications for Clinical Practice

Oct 24, 2012 13:00 EDT

Do rivaroxaban and ticagrelor really reduce mortality in patients with ACS? Drs. Bhatt, Storey, and Gibson provide their insights.

Thrombosis

Clinician Survey: Managing Stroke Risk in Patients With Atrial Fibrillation

Oct 16, 2012 12:55 EDT

Please take a moment to complete our survey on strategies to reduce the risk for stroke in patients with AF.

Thrombosis

Rethinking Thrombin: Strategies to Reduce Mortality in ACS

Sep 20, 2012 10:43 EDT

Dr. Eugene Braunwald leads an international panel of experts, Drs. Bode, Fox, Verheugt, and Weitz, in a review of anticoagulation post-ACS.

Thrombosis

Evaluating the Cost-Effectiveness of Novel Anticoagulants to Prevent VTE After Orthopedic Surgery

Aug 2, 2012 00:00 EDT

Drs. Lassen and Mantovani discuss the cost-effectiveness of using novel oral anticoagulants after major orthopedic surgery.

Thrombosis

Treating Across the AF Risk Continuum: Patients with a Previous Stroke

Jul 30, 2012 12:00 EDT

Drs. Camm and Amarenco discuss the issues in managing anticoagulation for patients with AF who have already had a stroke

Prevention

The 2012 Global Stroke Prevention in Atrial Fibrillation Summit

Jul 24, 2012 13:59 EDT

Drs. Ezekowitz, Halperin, Becker, Eikelboom, and Lip discuss data regarding antithrombotic therapy for patients with nonvalvular AF, including issues of bleeding risk, dosing, and renal function.

Thrombosis

The Burdens of AF-Related Stroke: Concepts in Managing Economic and Human Costs

Jul 18, 2012 09:41 EDT

Drs. Hacke and Hankey discuss the financial and personal impact of AF-related stroke and how novel oral anticoagulants may improve outcomes.

Thrombosis

Oral Anticoagulation and Preventing Stent Thrombosis

Jul 17, 2012 14:47 EDT

Drs. Steg and Bassand discuss how the addition of novel oral anticoagulants to DAPT may prevent further ischemic complications following ACS.

Thrombosis

Anticoagulation in the Orthopaedic Setting: Comparing Real-World Experiences With Clinical Trials

Jun 22, 2012 16:09 EDT

Drs. Lassen, Turpie, and Mouret discuss how real-world experience with novel anticoagulants in orthopaedic surgery compares with trial data.

Thrombosis

Five Things You Need to Know about VTE

Jun 18, 2012 10:14 EDT

Drs. Goldhaber, Fox, and Harrington present 5 important things you need to know about VTE, AF-related stroke, and secondary prevention in ACS.

Prevention

Prevention and treatment of venous and arterial thromboembolic disease: The 9th ACCP guidelines

May 31, 2012 10:10 EDT

Drs. Ortel, Cohen, Goldhaber, Heit, Lincoff, and Lip offer new perspectives from the 9th ACCP guidelines on the prevention and treatment of thromboembolic disease.

Thrombosis

Evaluating Recent Clinical Trial Data in the Secondary Prevention of ACS

Apr 24, 2012 10:22 EDT

Drs. Gibson, Verheugt, Alexander, and Ohman discuss the evidence for using novel oral anticoagulants in patients following an ACS.

Thrombosis

Breaking Down Symptomatic DVT: Treatment Gaps in Recurrent Disease

Jan 23, 2012 10:50 EST

Novel oral anticoagulants hold the promise of simplifying the treatment of acute and recurrent VTE; Drs. Turpie, Agnelli, and Cohen discuss recent findings.

Thrombosis

Thinking Beyond Platelet Inhibition: Oral Anticoagulation for Secondary Prevention in ACS

May 6, 2011 14:42 EDT

When dual antiplatelet therapy fails, what are the options? Dr. Verheugt discusses the evolving concepts in secondary prevention of ACS in this clinical update.